Metastatic breast cancer trials recruiting in Alabama

All Metastatic breast cancer trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
  NCT06369285 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
  NCT06099769 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
  NCT05693766 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• PRE-ISPY Phase I/II Oncology Platform Program
  NCT05868226 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
  NCT06105684 · Phase: Phase 2 · Ages: 60 Years and older · Sex: Female · Alabama: Birmingham
• Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
  NCT06855654 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham